← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 1989Last known activity
Nov 17, 2024
Timeline
1980s
- Jan 1, 1989
National Human Genome Research Institute (NHGRI)— Founded
Drugs by trial phase (29 distinct, 29 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 2 (19 own, 0 via acquisition)
Phase 1 (8 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Albinism
- Albinism, Oculocutaneous
- Alkaptonuria
- Aphasia, Primary Progressive
- Ataxia
- Autoimmune Diseases of the Nervous System
- Cerebellar Ataxia
- Chromosome Deletion
- Cystinosis
- Developmental Disabilities
- Disease
- Distal Myopathies
- Erdheim-Chester Disease
- Fibrosis
- Frontotemporal Dementia
- Gangliosidoses
- Gangliosidosis, GM1
- Growth Disorders
- Hermanski-Pudlak Syndrome
- HIV Infections
- Immunologic Deficiency Syndromes
- Infections
- Intellectual Disability
- Melanoma
- Metabolic Diseases
- Metabolism, Inborn Errors
- Mitochondrial Diseases
- Muscular Diseases
- Nervous System Malformations
- Niemann-Pick Diseases
- Niemann-Pick Disease, Type A
- Niemann-Pick Disease, Type C
- Ochronosis
- Parasomnias
- Pick Disease of the Brain
- Platelet Storage Pool Deficiency
- Proteus Infections
- Proteus Syndrome
- Pulmonary Fibrosis
- Sarcoma
- Sarcoma, Kaposi
- Self-Injurious Behavior
- Severe Combined Immunodeficiency
- Sleep Disorders, Circadian Rhythm
- Sleep Wake Disorders
- Smith-Magenis Syndrome
- Spinocerebellar Ataxias
- Spinocerebellar Degenerations
- Syndrome
Recent trials (49)
- NCT06664814Lead sponsorPhase 2Nov 17, 2024
- NCT06664814OfficialPhase 2Nov 17, 2024
- NCT05778877CollaboratorPhase 1/Phase 2Dec 19, 2022
- NCT04717336Lead sponsorEarly Phase 1Jan 22, 2021
- NCT04316546Lead sponsorPhase 2Apr 23, 2020
- NCT04316546Overall official - principal investigatorPhase 2Apr 23, 2020
- NCT04231266CollaboratorPhase 2Feb 1, 2020
- NCT04231266Lead sponsorPhase 2Feb 1, 2020
- NCT04231266Sponsor investigatorPhase 2Feb 1, 2020
- NCT04231266Overall official - principal investigatorPhase 2Feb 1, 2020
- NCT03952637Overall official - principal investigatorPhase 1/Phase 2Jul 5, 2019
- NCT03952637Lead sponsorPhase 1/Phase 2Jul 5, 2019
- NCT03304717CollaboratorPhase 1/Phase 2Jan 31, 2018
- NCT02594215Overall official - principal investigatorPhase 1Oct 29, 2015
- NCT02594215Lead sponsorPhase 1Oct 29, 2015
Details
- Founded
- Bethesda, MD, US Jan 1, 1989
- Last known activity
- Nov 17, 2024